Literature DB >> 13011212

The relationship between the clearance and the plasma concentration of inulin in normal man.

T J KENNEDY, J KLEH, A B BARTOL, H C DICKERSON.   

Abstract

Entities:  

Keywords:  INSULIN/metabolism

Mesh:

Substances:

Year:  1953        PMID: 13011212      PMCID: PMC436531          DOI: 10.1172/JCI102715

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY.

Authors:  H W Smith; W Goldring; H Chasis
Journal:  J Clin Invest       Date:  1938-05       Impact factor: 14.808

2.  THE EXCRETION OF INULIN, XYLOSE AND UREA BY NORMAL AND PHLORIZINIZED MAN.

Authors:  J A Shannon; H W Smith
Journal:  J Clin Invest       Date:  1935-07       Impact factor: 14.808

3.  THE RENAL EXCRETION OF INULIN AT LOW PLASMA CONCENTRATIONS OF THIS COMPOUND, AND ITS RELATIONSHIP TO THE GLOMERULAR FILTRATION RATE IN NORMAL, NEPHRITIC AND HYPERTENSIVE INDIVIDUALS.

Authors:  B F Miller; A S Alving; J Rubin
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

4.  Attainment of equilibrium between plasma and urine, with reference to measurement of renal clearances.

Authors:  A J MICHIE; C R MICHIE
Journal:  J Urol       Date:  1951-10       Impact factor: 7.450

5.  Measurement and significance of urinary appearance time in the dog.

Authors:  P A MORALES; C H CROWDER; A P FISHMAN; M H MAXWELL; D M GOMEZ
Journal:  Am J Physiol       Date:  1950-11
  5 in total
  3 in total

1.  The renal clearance of alkali-stable inulin.

Authors:  M WALSER; D G DAVIDSON; J ORLOFF
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

2.  Molecular inhomogeneity as a source of error in inulin clearance studies.

Authors:  O BASSIR
Journal:  J Physiol       Date:  1956-03-28       Impact factor: 5.182

3.  Human resistin and the RELM of Inflammation in diabesity.

Authors:  Fatima Al Hannan; Kevin Gerard Culligan
Journal:  Diabetol Metab Syndr       Date:  2015-06-18       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.